Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention. Ridker PM. J Am Coll Cardiol 2021;77:1856-1858.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ridker PM. Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention. J Am Coll Cardiol 2021;77:1856-1858.
PMID: 33858621